Grail (NASDAQ:GRAL) Reaches New 1-Year High – What’s Next?

Grail, Inc. (NASDAQ:GRAL) shares hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $34.44 and last traded at $34.39, with a volume of 1457859 shares changing hands. The stock had previously closed at $28.28.

Analyst Ratings Changes

A number of analysts recently weighed in on GRAL shares. Wolfe Research began coverage on shares of Grail in a research note on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley began coverage on shares of Grail in a research report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective on the stock. Finally, Guggenheim initiated coverage on shares of Grail in a research report on Thursday, October 17th. They set a “neutral” rating for the company.

Grail Price Performance

The business has a fifty day moving average price of $21.43 and a 200 day moving average price of $17.04.

Grail (NASDAQ:GRAL) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The business had revenue of $28.65 million for the quarter. As a group, sell-side analysts forecast that Grail, Inc. will post -65.16 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the transaction, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Institutional Investors Weigh In On Grail

Several large investors have recently modified their holdings of the company. FNY Investment Advisers LLC purchased a new stake in Grail in the 4th quarter valued at $26,000. Lindbrook Capital LLC acquired a new position in Grail in the fourth quarter valued at $28,000. New York State Common Retirement Fund purchased a new stake in shares of Grail in the fourth quarter valued at about $59,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Grail during the fourth quarter worth about $64,000. Finally, PNC Financial Services Group Inc. purchased a new position in shares of Grail during the fourth quarter worth about $86,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.